Advertisement
<< Back To Article
Activists Protest Stribild's $28,500 Price Tag

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*

13 Comments

Frederick Wright

I can hear Gilead Science or their excutive saying,"What more do these people want?". You see the first tier pricing of 28,000 year is the game Gilead and all of Pharma play. With cash, if you have it is 20 percent discount off the top. No one buys in cash, however one can count on the government buying at Teir 2 for we paid the most in the world for life saving drugs. It is a secert what Teir 3 and Teir 4 are for big spenders like Human and Walgreen. Gilead we would like Tranparence and Truth.

October 1, 2012 Coachella Valley

Andy

All I read is so much BS justifying murderous prices so we can put someone's kid through Harvard or pay for a second house on an island. I don't care what their justification is, it's more than they need to make a fair profit. Let's talk about ways that the price can come down, not what their PR spin is on the pricing, or how Gilead will "lose esteem" in the eyes of physicians.

September 27, 2012

Vapur9

You're telling a for-profit company to price its temporary monopoly patents fairly? Get real. Your health is not their number one concern.

September 23, 2012

JrB

It is pricing imbalances like these that have kept me on the Federal Disability payroll for 4 years, and making it virtually impossible to go back to work and afford to pay for my own healthcare and living expenses. At just over $21,000 a year just for the pill to keep me alive I would have to make over $50,000 a year just to afford a basic apartment/lifestyle and that's INSANE! We need to stop the madness while large pharma get rich. CEO makes $34,000 an hour?! We all should be ashamed to allow

September 15, 2012 Austin, TX

KENNETH

Seems like the only way to afford this drug is to buy Gilead Stock and watch the stock price go up so fast that you can sell it and afford the medication because at this price the stock price should sky-rocket. Come on GILEAD you can do better than this... you stock price has done very well year after year after year. I know I purchased $15,000 and made over $100,000 in a rather short period of time.

September 6, 2012 Vallejo

Crystal

As much as I would like to believe that pricing is based on a possible cure in the near future, it isn't so. The patents on many current medications are running out within the next year. Meaning that other companies will be able to produce them at lower cost. To make up for all that lost revenue the will be pricing new medications being released at higher price points.

September 4, 2012 Texas

Frederick Wright

Again you gentlemen are giving to much power to these Bio Companies. Gilead is testing the waters to see if AIDS Activist still have political cloud as before, You all must understand that ADAP is the last arm of negoiation before price controls may come to the table and that is these folks fear. I must stress that the way the branch sway the roots will follow. Gilead knows the power of HIV advocates in the past and we must demand fair pricing, others will follow, ie 100 of cancer,dyalis,MS...

August 31, 2012 Coachella Valley

elizajane

It's no different than for-profit methadone clinics...where's the hurry to get folks off methadone when they are making a HUGE profit? There is none. Nor is there ever a push with big pharma, to find cures for anything. It's all about the bottom line and getting the highest return for investors...yay capitalism. The whole healthcare and insurance industry needs an overhaul; but as long as there are people making money from illness and/or medications, there will be no cure. For any disease.

August 30, 2012 Boston

Advertisement

Hot topics


POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.